Some of the price disparity may be attributed to local factors, including distance to the producing centres (Netherlands and Belgium), but statistical artefacts (e.g. small sample sizes) may also be a factor. Individual factors and sex affect this dose, with women considered to be more susceptible to the 5-HT-releasing effects of MDMA (Liechti et al., 2001). Harm reduction responses, including the provision of drug-checking services and appropriate risk-communication strategies, are crucial to minimise these risks. This is consistent with law enforcement information that suggests the MDMA market in Europe is supplied by the same pool of producers, mostly based in the Netherlands and Belgium. It should be noted that this trend was observed across several countries in Europ

A review of MDMA-related mortality in Australia and three European countries (Portugal, Finland and Türkiye) showed an increase in the number of fatalities between 2011 and 2017 (Roxburgh et al., 2021


Although very rarely reported, opioids may also be found in tablets buy mdma sold as MDMA. In the period from 2019 to 2023, caffeine, 4-CMC (4), amphetamine, cocaine and MDA were the adulterants most commonly found in MDMA samples (tablets and powders/crystals) submitted to drug-checking organisations belonging to the TEDI network. Again, these data should be interpreted with caution and not necessarily be seen as statistically representative of the market as a whole. Crystal MDMA appeared on the European market at that time, as a response to a fall in consumer confidence due to concerns about the low quality of ecstasy. However, adulteration is commonplace, and therefore these tablets may contain a variety of substances in addition to, or instead of, MDMA. Retail quantities sold online are often dispatched in post and parcels from EU Member States to consumer markets in Europe and globally, and cryptocurrencies are often used to settle these online transactions.
Da


Almost two thirds (503) of all new treatment entrants were reported from three countries, Germany (213); France (169) and Hungary (121). At EU and country level, people seeking drug treatment for MDMA-related problems represent a very small proportion of all clients entering drug treatment – typically less than 0.5 % of all new entrants into drug treatment in any given year. Demographic insights obtained from drug-related emergencies are in general buy mdma agreement with other data sources (see Section Prevalence and patterns of use

General / Short-Term Effects
MDMA is reported in small numbers of drug-induced deaths, and in most countries less than 1 in 20 cases involve the drug. While affected by limitations and uncertainties, this type of data analysis shows great promise as a complementary information source to monitor the size and changes in drug markets (Quireyns et al., 2023). It was possible to construct estimates of city-level MDMA market sizes by combining wastewater data with country-level data for average retail purity and price. By combining these data, the estimated annual value of the buy mdma retail market for MDMA in Europe is at least EUR 594 million, around 90 % of which can be attributed to frequent user

In fact, it could be argued that MDMA in the form of ecstasy tablets became cheaper between 2012 and 2019 as tablets containing larger quantities of MDMA became increasingly available on the market (see Section The trend of large tablets containing more MDMA may be reversing


Consumers in the Netherlands will typically pay EUR 4.50 per tablet but, as stated above, prices may reach as high as EUR 19 buy mdma per tablet in some European countries, and more in other regions of the world. According to Dutch Police, these tablets are sold to distributors at EUR 0.59 per unit (2022 values), who in turn re-sell them at EUR 1.78 each (for quantities above 99 tablets). The subsequent drop in MDMA content in tablets since 2019 does not appear to have been accompanied by a significant drop in price. In 2021, adult respondents to the EWSD reported paying a median of EUR 7.20 per ecstasy tablet and a median of EUR 37.40 per gram for MDMA powder. (a) In clinical trials, doses of MDMA capable of producing subjective effects vary from 1.5 to 1.7 mg/kg of body weight, or approximately 105 to 119 milligrams for a 70-kilogram individual.
Reporting countries
According to survey data, the two largest MDMA consumer markets per capita in the European Union are the Netherlands and Ireland, with 6 % or more people aged 15 to 34 reporting to have consumed MDMA in the last year. Some of the high-strength ecstasy tablets are scored to allow consumers to divide them into smaller portions. These identifications of high-strength ecstasy tablets prompted harm reduction organisations to issue alerts. In December 2023, beige-golden ecstasy pills with an Audi-logo containing over 300 milligrams of MDMA (between 316 and 324 milligrams) were submitted to drug testing in the Netherlands (DIMS, 2023). However, this trend appears to be changing, as ecstasy tablets have tended to contain less MDMA since 201